Smartphones are taking a shot at slenderizing in a nod to Ben Stiller’s itty-bitty mobile in the early-aughts classic ...

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

Shamoon has joined the wave of people who are taking limited amounts not of psychedelics — to which the microdosing trend usually applies — but of the diabetes drug Ozempic (semaglutide), and ...

Ozempic has gained widespread recognition in recent years as a leading treatment for managing certain health conditions, such as type 2 diabetes and weight loss.

Add surgical tweaks to fix so-called "Ozempic face" to the list of top trending cosmetic procedures, as tallied by the American Academy of Facial Plastic and Reconstructive Surgery. The group's ...

A rising number of people have accepted GLP-1s as a way to treat obesity, which affects more than 100 million Americans. © 2024 Fortune Media IP Limited. All Rights ...

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks associated with ...

Ozempic (semaglutide) is a brand-name drug prescribed to treat certain conditions, such as type 2 diabetes. Ozempic has interactions with some other drugs, such as insulin, and certain supplements ...

Weight loss from GLP-1 meds can cause faces to sag, spurring a big uptick in plastic surgeries to correct so-called 'Ozempic face' Nose jobs, facelifts and eye lifts still top the list of most ...